Library resources - Almac

Home / Knowledge Centre /

Clinical Technologies

Search

Topic

What is IRT and How Does it Impact Clinical Trials?

What is Interactive Response Technology (IRT) or Randomization and Trial Supply Management System (RTSM)? An IRT system is known by…

Unique IRT implementation considerations for personalised medicine trials

Unique IRT implementation considerations for personalised medicine trials

Almac Clinical Technologies Biostatistics Group

Technical Sheet

Almac Clinical Technologies Biostatistics Group

Master Protocols: Implementing effective treatment adaptations in the randomisation

Master Protocols: Implementing effective treatment adaptations in the randomisation

Jennifer Ross

Interactive Response Technology User Support: Where eClinical Software and a Site-Centric Mindset Converge

Interactive Response Technology User Support: Where eClinical Software and a Site-Centric Mindset Converge

Make an Enquiry

If you are interested in our Clinical Technologies, then please contact us

Leveraging IRT User Acceptance Testing Strategy to Navigate Clinical Trial Complexity

Streamlining Clinical Trial Supply Management and Reporting with Drug Pooling in the IRT World

Technical Sheet

IXRS®3 Decentralised Trials Support

Technical Sheet

IXRS®3 Drug Pooling: Multi-protocol supply management

Technical Sheet

ART™ (Accountability & Reconciliation Tracking)

Rapid Onboarding for Master Protocols

Managing regulated IP in Japan

A two-month lockdown in Shanghai

Supporting small domestic trials cost effectively

Care is Critical- Lessons Learned from Clinical Trial Inspections

How DCT Technology Partnerships a Better Patient Journey, Diversity, and Adherence

Is Your IRT Ready to Support Direct-to-Patient Shipments?

Innovative Electronic Patient Identification System

Flexible IXRS® design supports multiple extension studies

Ensuring study integrity and reliability during a drug recall

Boehringer Ingelheim relies on Almac Clinical Technologies for EDC/IRT integration

Accommodating Last-Minute Design Changes

Meeting regulatory requirements in Japan: Customised IXRS® manages patient-specific drug orders

Weighing the options in addressing a supply issue

Total supply chain assurance program turns around global trial

Temperature Surveillance

Supporting a regulatory submission proactively

Supplying costly investigational product: Pre-randomisation approach reduces drug wastage

Smooth operations after a cyberattack: Quick thinking and extra coordination preserves drug supply and patient safety

Seamless adoption of mid-study protocol change

Preparing “Plan B” for a mega study in the event of a supply issue

Managing drug and dose assignments

Managing 24 protocol amendments across a complex development program

Maintaining compliance with new ICH monitoring guidelines

Clinical Trials Need Preventative Maintenance Just Like Cars Do, and Here is Why

5 Points of Operational Readiness

Automated Accountability and Reconciliation

Supporting the race for a COVID-19 therapy

State of the Industry Report: Embracing Trial Change and Elevating IRT Systems

The secrets of a successful supply strategy

IRT system customisations – necessary or nice to have?

Catching up during COVID: Proven technology for meeting accelerated timelines

Accelerating Outcomes with a Pancreatic Cancer Adaptive Platform

Adaptations and Solutions for Clinical Supply Chain Challenges

So, you want to run a decentralised clinical trial…

How to Add a New Randomized Part to an Ongoing Study in Three Weeks

Accommodating a Flexible Visit Schedule

Impact of Missing ePRO Data on Clinical Trials

Clinical Practice Is Ahead Of Clinical Trials With Technology Use: EMR VS. ePRO

A Competitive Race: Accelerating the Development Timeline With A Multi-Trial IRT Programme

ART™ – Automated Accountability: Maintaining a chain of custody from release to destruction

How to successfully optimise your clinical supply with IRT

Understanding Data Integrations Designs for Clinical Trial Vendors

Easing the Burden of Clinical Trial Participation for Children with Rare Diseases

Navigating a Rare Disease: A Mother’s Story

Do I need an IRT/RTSM for my Clinical Trial?

What is Randomisation and Trial Supply Management (RTSM)?

<img src="https://www.almacgroup.com/knowledge/wp-content/uploads/sites/10/2021/08/jenn-ross-headshot.png" alt="Expert name: Jennifer Ross" >

Elevating Study Experience in Decentralised Clinical Trials: How IRT Can Help

Beyond the Audit: Taking Quality and Compliance to New Heights with Your IRT

Entering the World of Complex Innovative Designs: What does this mean for the Randomisation?

<img src="https://www.almacgroup.com/knowledge/wp-content/uploads/sites/10/2021/08/jenn-ross-headshot.png" alt="Expert name: Jennifer Ross" >

Streamlining Clinical Trial Supply Management and Reporting with Drug Pooling in the IRT World

ART™: Crafting an Automated Tool for Accountability and Reconciliation Tracking

UAT: A Custom-Built Roadmap to Kick Off Your Clinical Trial Journey

Transforming Patient Data with Interactive Responsive Technology (IRT) Data Integration

IRT User Support: A Key Piece to the Clinical Trial Puzzle

Improve your Clinical Supply Chain Management Using IRT

Common Randomisation Methodologies Implemented in IRT

What is IRT and How Does it Impact Clinical Trials?

Integrating the digital and physical supply chain: Optimal performance, reduced risks, and lower costs

Barring the Electronic Door: How to Secure Mobile Devices Used in Clinical Trials

Are you equipped with an inspection-ready IRT?

6 Best Practices in IRT Implementation for Clinical Trials in APAC

The Burden of Regulatory Compliance

Simplify™ IRT: A competitive advantage to accelerate clinical trials

Meet the Experts

Learn more about our experts in your discipline today

Stay up-to-date with the latest from Almac

Join our mailing list

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies